Panakeia is a software development company based in London, England, focused on rapid, instrument-free precision cancer diagnostics using AI technology.

Panakeia provides an AI platform enabling simplified, rapid diagnostics to inform the precision treatment of cancer. They offer comprehensive multi-omics molecular analysis of patient tissues faster and more cost-effectively than traditional methods. Their AI-driven PANProfiler platform delivers fast, accurate molecular insights from routine pathology slides, helping clinicians make same-day treatment decisions, reducing pressure on NHS labs, and improving patient outcomes.

Products are intended for research use only, not for diagnostic procedures.
They serve both clinical diagnostics and drug development sectors.

Founded in 2018, Panakeia is a privately held company headquartered in London, England. The company has 11-50 employees and specializes in Machine Learning, Deep Learning, Artificial Intelligence, Cancer Diagnostics, and Personalized Medicine.

Primary location: 30 Aldwych, London, England, GB.

Panakeia is committed to accelerating molecular insights and ensuring timely, precise cancer care. The team consists of leading clinicians, scientists, and engineers dedicated to solving challenges in rapid access to quality healthcare.

Currently, there are no active job postings on their website, but they welcome prospective applications at [email protected].

Contact email: [email protected]

Website: https://panakeia.ai